Oral manifestation of thalassemia  mayor: case study

Haris B. Widodo(1), Aisya E. Maharani(2),

(1) Department of Oral Biology Faculty of Medicine Jenderal Soedirman University, Purwokerto, Indonesia
(2) Integration Clinic Dental Hospital of Jenderal Soedirman University, Purwokerto, Indonesia


Objective: Thalassemia b major is one of inheredited blood disorder caused by abnormality hemoglobin. Thalassemia b major is widely found in population Mediteranian with prevalent ±25.000 case. The abnormal form of hemoglobin chain will lead to erythrocytes damage in <120 days and will distrurb osteogenesis process. This condition caused patient with thalassemia b major require blood transfusion. The purpose of this paper is to describe an oral manifestation of thalassemia b major.

Methods: the patient (5 years old) came to dental hospital of Jenderal Soedirman University with his mother for having teeth treatment. The patient was diagnosed thalassemia b major since 1 years old of and has had regular blood transfusion every month. An examination of intraoral examination showed pale oral mucose (purplish), profound caries on 85th teeth exposed to pulp, overbite 4mm, overjet 3mm, deep palatum, and the extraoral examination showed special face shape.

Results: Clinical examinations performed on patients showed the characteristics of cooley-face and the cephalo-tracing x-ray result, the were <SNA = 86o, <SNB = 81o, <ANB = 5o, and <FH-Man = 35o. Based on the radiographic results it can be seen that patients with thalassemia have skeletal class II tendency and there is more anterior or protusive appearence of maxillary growth.

Conclusion: Thalassemia sufferers have oral manifestations which are characterized by Cooley-face. Patients with thalassemia have skeletal class II tendency and there is more anterior or protusive appearence of maxillary growth.

Hemoglobin, Oral manifestation, Thalassemia b mayor.

Full Text:



Mustafa MA, Thiru EM. IIzam HF, et al. Pathophysiology Clinical Manifestation and Carrier Detection in Thalessemia. IOSR J Dent & Med Sci 2016;15: 122-126.

Brown BA. Hematology principles and prosedures. 3rd ed. Philadelphia: Lea & Febiger; 1980.

Cunningham MJ, Macklin EA, Neufeld EJ. Thalassemia Clinical Research Network. Complications of Beta-Thalassemia Major in North America. Blood. 2004, 104: 34-39.

Orgna C, Rugolotto S, De Stefano P, Zhao H. Survival and Complications in Patients With Thalassemia Major Treated With Transfusion and Deferoxamine. Haematologica. 2004;89: 1187-1193.

Gaudio A, Morabito N, Xourafa A, Macri I, Meo A, Morgante S, Trifiletti A. Bisphosphonates in The Treatment of Thalassemia-associated Osteoporosis. J Endocrinol Invest. 2008;31: 181-184.

Burgest TS, Qian Y, Kaufman. The Ligand For Osteoprotegerin (OPGL) directly activates mature osteoclast. J Cell Boil 1999;145; 527-537.

Singh, G. Textbook of Orthodontics. New Dhelhi: Jaype Brothers Medical Publisher; 2007.

Ragab LA, Hamdy MM, Shaheen IA, Yassin RN. Blood Transfusion Among Thalassemia Patients: a Single Egyptian Center Experience. Asian J Transfus Sci. 2013;7:33–36.

Domellöf M, Dewey KG, Lönnerdal B, Cohen RJ, Hernell O. The diagnostic criteria for iron deficiency in infants should be reevaluated. J Nutrion. 2002;132:3680–6.

Kelleher SL. Effects Of Age and Mineral Intake on The Regulation of Iron Absorption in Infants. Journal Pediatr. 2006;149:69–73.

Perrotta S, Cappellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Siciliani MC, Iolascon A. Osteoporosis in β-thalassemia Major Patients: Analysis of The Genetic Background. Br Journal Haematol. 2000, 111: 461-466.

Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone Mineral Metabolism in Adults with β-thalassemia Major and Intermedia. Br Journal Haematol. 2000, 111: 902-907.

Galanello R, Raffaella O. Beta Thalassemia. Orphanet J Rare Diseases 2010;5; 156-163.






  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License. View My Stats